Literature DB >> 28099803

Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

Tyler B Hughes1, S Joshua Swamidass1.   

Abstract

Many adverse drug reactions are thought to be caused by electrophilically reactive drug metabolites that conjugate to nucleophilic sites within DNA and proteins, causing cancer or toxic immune responses. Quinone species, including quinone-imines, quinone-methides, and imine-methides, are electrophilic Michael acceptors that are often highly reactive and comprise over 40% of all known reactive metabolites. Quinone metabolites are created by cytochromes P450 and peroxidases. For example, cytochromes P450 oxidize acetaminophen to N-acetyl-p-benzoquinone imine, which is electrophilically reactive and covalently binds to nucleophilic sites within proteins. This reactive quinone metabolite elicits a toxic immune response when acetaminophen exceeds a safe dose. Using a deep learning approach, this study reports the first published method for predicting quinone formation: the formation of a quinone species by metabolic oxidation. We model both one- and two-step quinone formation, enabling accurate quinone formation predictions in nonobvious cases. We predict atom pairs that form quinones with an AUC accuracy of 97.6%, and we identify molecules that form quinones with 88.2% AUC. By modeling the formation of quinones, one of the most common types of reactive metabolites, our method provides a rapid screening tool for a key drug toxicity risk. The XenoSite quinone formation model is available at http://swami.wustl.edu/xenosite/p/quinone .

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28099803      PMCID: PMC5871348          DOI: 10.1021/acs.chemrestox.6b00385

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  101 in total

Review 1.  Quinone chemistry and toxicity.

Authors:  T J Monks; R P Hanzlik; G M Cohen; D Ross; D G Graham
Journal:  Toxicol Appl Pharmacol       Date:  1992-01       Impact factor: 4.219

2.  Exposition and reactivity optimization to predict sites of metabolism in chemicals.

Authors:  Gabriele Cruciani; Massimo Baroni; Paolo Benedetti; Laura Goracci; Cosimo Gianluca Fortuna
Journal:  Drug Discov Today Technol       Date:  2013

3.  EaMEAD: Activation energy prediction of cytochrome P450 mediated metabolism with effective atomic descriptors.

Authors:  Doo Nam Kim; Kwang-Hwi Cho; Won Seok Oh; Chang Joon Lee; Sung Kwang Lee; Jihoon Jung; Kyoung Tai No
Journal:  J Chem Inf Model       Date:  2009-07       Impact factor: 4.956

Review 4.  The chemistry of contact allergy: why is a molecule allergenic?

Authors:  D Basketter; A Dooms-Goossens; A T Karlberg; J P Lepoittevin
Journal:  Contact Dermatitis       Date:  1995-02       Impact factor: 6.600

5.  In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.

Authors:  Mukesh K Mahajan; Vinita Uttamsingh; J Scott Daniels; Liang-Shang Gan; Barbara W LeDuc; David A Williams
Journal:  Drug Metab Dispos       Date:  2010-12-21       Impact factor: 3.922

6.  Immune pathomechanism of drug hypersensitivity reactions.

Authors:  Werner J Pichler; Dean J Naisbitt; B Kevin Park
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

7.  Nephrotoxicity and diagnostic agents.

Authors:  G E Schreiner
Journal:  JAMA       Date:  1966-05-02       Impact factor: 56.272

Review 8.  The generation, detection, and effects of reactive drug metabolites.

Authors:  Andrew V Stachulski; Thomas A Baillie; B Kevin Park; R Scott Obach; Deepak K Dalvie; Dominic P Williams; Abhishek Srivastava; Sophie L Regan; Daniel J Antoine; Christopher E P Goldring; Alvin J L Chia; Neil R Kitteringham; Laura E Randle; Hayley Callan; J Luis Castrejon; John Farrell; Dean J Naisbitt; Martin S Lennard
Journal:  Med Res Rev       Date:  2012-10-22       Impact factor: 12.944

9.  Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.

Authors:  Jonathan N Bauman; Kosea S Frederick; Aarti Sawant; Robert L Walsky; Loretta M Cox; Ronald S Obach; Amit S Kalgutkar
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

10.  Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts.

Authors:  Ping Kang; Deepak Dalvie; Evan Smith; Matt Renner
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

View more
  16 in total

Review 1.  The application of artificial neural networks in metabolomics: a historical perspective.

Authors:  Kevin M Mendez; David I Broadhurst; Stacey N Reinke
Journal:  Metabolomics       Date:  2019-10-18       Impact factor: 4.290

2.  Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2018-02-06       Impact factor: 3.739

3.  Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2017-03-14       Impact factor: 3.739

4.  In Silico Tools and Software to Predict ADMET of New Drug Candidates.

Authors:  Supratik Kar; Kunal Roy; Jerzy Leszczynski
Journal:  Methods Mol Biol       Date:  2022

5.  Site-Level Bioactivity of Small-Molecules from Deep-Learned Representations of Quantum Chemistry.

Authors:  Kathryn Sarullo; Matthew K Matlock; S Joshua Swamidass
Journal:  J Phys Chem A       Date:  2020-10-21       Impact factor: 2.781

6.  Modeling the Bioactivation and Subsequent Reactivity of Drugs.

Authors:  Tyler B Hughes; Noah Flynn; Na Le Dang; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

7.  Impacts of diphenylamine NSAID halogenation on bioactivation risks.

Authors:  Mary Alexandra Schleiff; Sasin Payakachat; Benjamin Mark Schleiff; S Joshua Swamidass; Gunnar Boysen; Grover Paul Miller
Journal:  Toxicology       Date:  2021-06-06       Impact factor: 4.571

8.  The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors.

Authors:  Na Le Dang; Matthew K Matlock; Tyler B Hughes; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-02-24       Impact factor: 4.956

9.  Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Authors:  Tyler B Hughes; Na Le Dang; Ayush Kumar; Noah R Flynn; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-09-16       Impact factor: 4.956

10.  Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.

Authors:  Noah R Flynn; Michael D Ward; Mary A Schleiff; Corentine M C Laurin; Rohit Farmer; Stuart J Conway; Gunnar Boysen; S Joshua Swamidass; Grover P Miller
Journal:  Metabolites       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.